Navigation Links
Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
Date:5/15/2008

APPENZELL, Switzerland, May 15 /PRNewswire/ -- Ergonex Pharma today announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to Terguride for the treatment of pulmonary arterial hypertension (PAH). Terguride is currently being evaluated for PAH in a pivotal Phase II trial in Europe.

"The FDA's grant of orphan drug designation to Terguride for PAH encourages and strengthens our development program by offering regulatory, clinical development and commercial benefits," said Dr Rudolf Reiter, CEO of Ergonex Pharma. "We believe that Terguride can provide a significant therapeutic benefit in PAH by inhibiting excess serotonin signalling."

The U.S. Orphan Drug Act is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases, which affect 200.000 persons or less in the United States. Under the Orphan Drug Act, upon marketing authorization, the FDA does not accept or approve other applications to market the same medicinal product for the same indication for a seven-year period. In addition to potential market exclusivity, orphan drug designation provides protocol assistance, advice on the conduct of clinical trials, tax credits for clinical research expenses, grant funding for research of rare disease treatments and waiver of the Prescription Drug User Fee Act filing fee.

About Terguride

Terguride has strong anti-serotoninergic activity by acting as a potent antagonist on 5-HT2B and 5-HT2A receptors: It has anti-proliferative and anti-fibrotic activity and drives reverse remodelling processes. Serotonin is a signal molecule in the body with many functions. In the blood vessel walls of the lung it stimulates proliferation of smooth muscle cells and narrowing of the blood vessels, which leads to PAH. Excessive proliferative effects of serotonin on the heart contribute directly to progression towards heart failure.

Terguride is cli
'/>"/>

SOURCE Ergonex Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has announced the addition ... Business Report" report to their offering. The ... Canada , Japan , ... of World. Annual estimates and forecasts are provided for the ... provided for these markets. The global market is ...
(Date:5/6/2015)... DUBLIN , May 06, 2015 Research ... announced the addition of the "Asia-Pacific Internal ... End-User - Analysis and Forecast To 2019" ... Internal Trauma Fixation Devices market is estimated to ... to 2019. Factors, such as technological advancement, rising ...
(Date:5/6/2015)... YORK , May 6, 2015   CEFALY ... electrical nerve stimulation device specifically authorized for use prior ... announce significant breakthroughs in migraine treatment at the EUROHEADPAIN ... in Valencia, Spain , from May ... at a meeting of EUROHEADPAIN, a major European research ...
Breaking Medicine Technology:Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2
... HONG KONG , July 22 /PRNewswire-Asia-FirstCall/ ... ("Golden,Meditech" or the "Group," HKEx: 801) is pleased to ... March 2010 . During the reporting period, total ... consolidate revenue from the,cord blood banking division into its ...
... , July 22 Nile Therapeutics, Inc. (Nasdaq: ... therapeutics for cardiovascular disease, today announced the appointment of Richard ... biotech and pharmaceutical industry experience, Mr. Brewer brings a wealth of ... , , ...
Cached Medicine Technology:Golden Meditech Announces Annual Results for FY 2009/10 2Golden Meditech Announces Annual Results for FY 2009/10 3Golden Meditech Announces Annual Results for FY 2009/10 4Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors 2Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors 3Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors 4
(Date:5/6/2015)... Locally owned, Greek olive oil producer and importer, ... as having one the best Extra Virgin Olive Oils in ... region of Greece and known as Laconiko , received ... Medium Olive Oil, which is defined by the competition as ... 700 producer applicants from 25 different countries applying, Laconiko stood ...
(Date:5/6/2015)... May 06, 2015 Topical BioMedics, Inc., announces ... May 12th, from 12pm – 1pm, streamed live and then ... and open to the public by clicking on the following ... attendees are invited “real time” during the webinar, and questions ... , The topic for the May webinar is ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 ... Hollywood, Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe ... top providers of products and services that maintain ... Debbie Durkin, Los Angeles’ leading producer of TV ... Lunge is a premier red carpet event that ...
(Date:5/6/2015)... In celebration of their twentieth anniversary, ... they will give away a deluxe human hair lace wig ... steps to enter on a third-party giveaway tool. The important ... can be the winner. , The hair is a crown, ... destination for such a jewel for the past 20 years. ...
(Date:5/6/2015)... Qualidigm , the national healthcare ... executive Ann Olson, RN, BSN, as a principal ... growing home healthcare services and develop strategic initiatives ... safety, and cost-effectiveness of healthcare through transformational change. ... of North Haven, Inc., a full-service home healthcare ...
Breaking Medicine News(10 mins):Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Choices Recovery Mishawaka Discusses the Many Forms of Addiction and Treatment with Terrah Bennett Smith 2Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3
... PLYMOUTH, Minn., Feb. 6 ev3 Inc. (Nasdaq: ... financial results and its financial guidance for 2009 on Tuesday, ... host a conference call and webcast the same day at ... management will review its fourth quarter and full-year operating results ...
... licensed practical nursing career resource center to learn about the many ... , ... Seattle, Washington (PRWEB) February 6, 2009 -- ... offers comprehensive career and education information for those who are ...
LOS ANGELES, Feb. 5 To clarify a comment I erred in making to a Los Angeles Times reporter, there was no payment of any sort by the NBC network to our client, Nadya Suleman, for her interview with ...
... Stater Bros. has raised over $1.9 million in the ... Bros. is once again partnering with the American Heart ... Heart Month, to help fight heart disease and stroke. ... "Have A Heart, Save A Heart" campaign to raise ...
... Feb. 5 ReBuilder Medical Technologies, Inc. (Pink Sheets: ... for diabetic peripheral neuropathy and Molluscum ... in sales for the month of January. (Logo: ... to be recession proof and this monthly sales turn ...
... New Rochelle, NY, February 5, 2009With the Obama ... health care reform, which at its core should ... prevention, chiropractic, and complementary and alternative medicine (CAM), ... (Volume 15, Number 1) of The Journal ...
Cached Medicine News:Health News:ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009 2Health News:Licensed Practical Nurse Career Resource Center Launches 2Health News:Licensed Practical Nurse Career Resource Center Launches 3Health News:Stater Bros. Campaigns to Fight Heart Disease and Stroke... At All Stater Bros. Supermarket Locations 2Health News:ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09 2Health News:Alternative and complementary medicine should have role in new era of health care reform 2
The HEP-1 system accommodates mini to full size gels with a transfer area of 20cmWx 20cmL, designed specifically for the transfer from polyacrylamide or agarose gels....
... from agarose gels to hybridization membranes in ... and efficiency of transfer by allowing high ... of an integrated system allowing electrophoresis, gel ... hours, versus 29 hours required for conventional ...
Trans-Blot Plus Gel/Cassette Assembly Tray...
A blotter fit for use with the incredible new Criterion precast gel system, the Criterion blotter combines excellent blotting efficiency with the flexibility of the Trans-Blot system and the ease-of-...
Medicine Products: